4.7 Editorial Material

The importance of controlled clinical trials with extracellular vesicles

Related references

Note: Only part of the references are listed.
Editorial Material Biotechnology & Applied Microbiology

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection

Yan Leyfman et al.

MOLECULAR THERAPY (2023)

Article Pharmacology & Pharmacy

First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatments

Lorenzo Gibello et al.

Summary: This study aimed to investigate the effectiveness of autologous serum-derived extracellular vesicles (s-EVs) in promoting the healing process of chronic venous ulcers (CVUs). The results showed that s-EVs treatment could accelerate tissue regeneration, reduce ulcer size, and alleviate inflammation in CVUs patients. The findings suggest that s-EVs hold clinical potential for the treatment of CVUs.

PHARMACOLOGICAL RESEARCH (2023)

Article Cell Biology

First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing

Jancy Johnson et al.

Summary: The release of growth factors, cytokines, and extracellular matrix modifiers by activated platelets plays a vital role in healthy wound healing. Extracellular vesicles (EVs) released by activated platelets carry these bioactive substances and have the potential to be used as a therapeutic option for delayed wound healing. This study demonstrates that Ligand-based Exosome Affinity Purification (LEAP) chromatography can successfully isolate clinical-grade platelet EVs (pEVs) that retain the regenerative properties of the parent cells, showing promise for potential use in wound healing treatments.

JOURNAL OF EXTRACELLULAR VESICLES (2023)

Review Pharmacology & Pharmacy

Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations

Natalia L. Klyachko et al.

PHARMACEUTICS (2020)